Optegra Eyes New Horizon with EssilorLuxottica Acquisition
Deal News | May 30, 2025 | Mid Europa Partners
Mid Europa Partners has announced the sale of Optegra, a prominent European ophthalmology platform, to EssilorLuxottica, a global leader in vision care. Under MidEuropa's stewardship, Optegra expanded significantly, entering new markets in Slovakia and the Netherlands, establishing new clinics in the UK, and acquiring eight companies across five countries. Utilising advanced AI technologies, MidEuropa optimized Optegra's operations, particularly in cataract care, and upheld a robust M&A strategy that strengthened its market position. The transaction, set to conclude later this year pending regulatory approval, marks a pivotal expansion for EssilorLuxottica and a potent new phase for Optegra. This marks yet another significant exit for MidEuropa, adding momentum to a year of successful divestments.
Sectors
- Healthcare
- Private Equity
- Technology
Geography
- Europe – Optegra operates across numerous locations in Europe, including Slovakia, the Netherlands, and the UK, which were notable areas of expansion.
- Global – EssilorLuxottica is characterized as a global player in the vision care and med-tech industry.
Industry
- Healthcare – The article revolves around Optegra's operations as an ophthalmology platform, focusing on medically necessary treatments and elective procedures in eye care.
- Private Equity – MidEuropa Partners, a private equity firm, is actively managing its portfolio through strategic acquisitions and exits, as illustrated by their divestment of Optegra.
- Technology – The article mentions the use of AI-driven assistants in healthcare, indicating a tech-driven approach to improving operational efficiency.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Mid Europa Partners | Selling Company | Company | A private equity firm responsible for the strategic management and successful expansion of Optegra. |
| Optegra | Target Company | Company | A prominent European ophthalmology platform that has expanded significantly under MidEuropa's ownership. |
| EssilorLuxottica | Bidding Company | Company | A global leader in the vision care, eyewear, and med-tech industry, acquiring Optegra to enhance its footprint in the eye care sector. |
| Houlihan Lokey | Financial Adviser | Company | Provided financial advisory services to MidEuropa for the transaction. |
| White & Case | Legal Adviser | Company | Offered legal counsel to MidEuropa during the sale process. |
| PricewaterhouseCoopers | Financial and Tax Adviser | Company | Advised on financial and tax matters for MidEuropa. |
| LEK and Mansfield Advisors | Commercial Advisers | Company | Provided commercial consultancy to MidEuropa. |
| Pawel Malicki | Partner | Person | A partner at MidEuropa who commented on the strategic significance of the transaction. |
| Robert Knorr | Managing Partner | Person | Managing Partner at MidEuropa, described the firm's accomplishments and strategic insights. |
| Dr. Peter Byloos | CEO | Person | CEO of Optegra, spoke on the transformative impact of joining EssilorLuxottica. |